PODCAST-19: FiveThirtyEight on the Novel Coronavirus
En podcast av FiveThirtyEight, Anna Rothschild
46 Avsnitt
-
Pandemics Don't Really End
Publicerades: 2021-07-14 -
How The CDC's Blindspots Complicated The Fight Against COVID-19
Publicerades: 2021-06-30 -
The Lab Leak Commotion
Publicerades: 2021-06-02 -
Who Should Decide Who Gets To Make COVID-19 Vaccines?
Publicerades: 2021-05-22 -
How To Make Sure Your Kid Isn't A Superspreader
Publicerades: 2021-05-07 -
You Might Have Given The Coronavirus To Your Cat
Publicerades: 2021-04-28 -
What A Donated Vaccine Can Do
Publicerades: 2021-04-22 -
The Johnson & Johnson Pause Shows The System Is Working
Publicerades: 2021-04-13 -
What The Heck Is Going On With AstraZeneca's Vaccine?
Publicerades: 2021-03-26 -
How To Overcome Vaccine Hesitancy
Publicerades: 2021-03-22 -
The COVID-19 Endemic
Publicerades: 2021-03-06 -
How Variants Complicate Everything
Publicerades: 2021-02-19 -
The Ethical Dilemmas Prompted By The Vaccine Rollout
Publicerades: 2021-02-05 -
What Happens Once You Get An mRNA Vaccine
Publicerades: 2021-01-15 -
Answering All (Or At Least Some) Of Your Vaccine Questions
Publicerades: 2021-01-07 -
The Dr. Fauci Holiday Special
Publicerades: 2020-12-22 -
Why Emily Oster Made Her Own COVID-19 Database
Publicerades: 2020-12-11 -
How To Trust That A COVID-19 Vaccine Is Safe
Publicerades: 2020-11-21 -
There's No Longterm Plan For Long COVID
Publicerades: 2020-11-13 -
What To Make Of Pfizer's Big Vaccine Announcement
Publicerades: 2020-11-10
FiveThirtyEight's COVID-19 podcast is laser-focused on evidence. What do we know about the novel coronavirus, and what do we know we don't know? COVID-19 has pushed Americans into more uncertain territory than most have ever known. Our podcast helps listeners understand what they can be certain about, and what is still unknown. We investigate coronavirus mysteries, debate when it's safe to reopen the economy and keep track of the latest scientific developments on vaccines and treatments. We do it all with FiveThirtyEight's trademark blend of transparency and rigor.
